Literature DB >> 12757050

Factors associated with humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of tuberculosis.

V M C Silva1, G Kanaujia, M L Gennaro, D Menzies.   

Abstract

SETTING: Tertiary care chest hospital in Montreal, Canada, where the average annual incidence of TB is 10/100,000 population.
OBJECTIVES: To evaluate the clinical correlates of humoral response to three Mycobacterium tuberculosis antigens.
METHODS: Humoral response to three M. tuberculosis antigens, 38 kDa, 14 kDa and ESAT-6, was measured with ELISA in patients with a spectrum of TB-related conditions. The association of positive tests for each antigen, defined with receiver operator characteristics (ROC) analysis, and patient characteristics was assessed in multivariate regression.
RESULTS: A total of 383 patients underwent serologic testing. In multivariate analysis, humoral response to 38 kDa was associated with active disease, response to 14 kDa was associated with inactive TB and female sex, and response to ESAT-6 with inactive TB, female sex, prior contact with TB, and recent arrival in Canada from high prevalence countries.
CONCLUSIONS: Response to the 38 kDa antigen was associated with current active disease, and was very different from response to the 14 kDa and ESAT-6 antigens. These latter two antigens were associated with risk factors for future active, but not current disease, suggesting that they might be useful to identify persons with higher risk of reactivation of latent TB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757050

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  35 in total

1.  Recognition of ESAT-6 sequences by antibodies in sera of tuberculous nonhuman primates.

Authors:  G V Kanaujia; S Motzel; M A Garcia; P Andersen; M L Gennaro
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung.

Authors:  Lanbo Shi; Robert North; Maria Laura Gennaro
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Immunochromatographic IgG/IgM test for rapid diagnosis of active tuberculosis.

Authors:  Walid Ben-Selma; Hedi Harizi; Jalel Boukadida
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

4.  Antituberculosis IgG antibodies as a marker of active Mycobacterium tuberculosis disease.

Authors:  Ryan J Welch; Kathleen M Lawless; Christine M Litwin
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

5.  The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes.

Authors:  Saet-Byel Jung; Chul-Su Yang; Ji-Sook Lee; A-Rum Shin; Sung-Soo Jung; Ji Woong Son; Clifford V Harding; Hwa-Jung Kim; Jeong-Kyu Park; Tae-Hyun Paik; Chang-Hwa Song; Eun-Kyeong Jo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 6.  Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis.

Authors:  Karen R Steingart; Nandini Dendukuri; Megan Henry; Ian Schiller; Payam Nahid; Philip C Hopewell; Andrew Ramsay; Madhukar Pai; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

7.  Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients.

Authors:  Shajo Kunnath-Velayudhan; Amy L Davidow; Hui-Yun Wang; Douglas M Molina; Vu T Huynh; Hugh Salamon; Richard Pine; Gerd Michel; Mark D Perkins; Liang Xiaowu; Philip L Felgner; JoAnne L Flynn; Antonino Catanzaro; Maria L Gennaro
Journal:  J Infect Dis       Date:  2012-06-25       Impact factor: 5.226

8.  Antibody profiles characteristic of Mycobacterium tuberculosis infection state.

Authors:  Amy Davidow; Ganga V Kanaujia; Lanbo Shi; Justin Kaviar; Xudong Guo; Nackmoon Sung; Gilla Kaplan; Dick Menzies; Maria L Gennaro
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

9.  Assessment of three commercially available serologic assays for detection of antibodies to Mycobacterium tuberculosis and identification of active tuberculosis.

Authors:  Brian L Anderson; Ryan J Welch; Christine M Litwin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

10.  Serodiagnostic efficacy of Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex, ESAT-6, and CFP-10 in patients with active tuberculosis.

Authors:  Gavish Kumar; Pradeep Kumar Dagur; Prashant Kumar Singh; Hari Shankar; Virendra S Yadav; Vishwa M Katoch; Bharat Bajaj; Rajesh Gupta; Utpal Sengupta; Beenu Joshi
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-01-05       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.